Pre-operative plasma D-dimer level may predict the poor prognosis within one year after the surgery for non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 14, Issue 6, 2011, Pages 534-537

  Wang, Zhe ^a   Fu, Junke ^a   Diao, Dongmei ^a   Dang, Chengxue ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

D dimer; Lung neoplasms; Prognosis

Indexed keywords

D DIMER;

ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER PATIENT; CANCER SURGERY; CHI SQUARE TEST; HUMAN; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROGNOSIS; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 79958754547     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2011.06.10     Document Type: Article

References (26)

1. Bick RL. Coagulation abnormalities in malignancy: a review. Semin Thromb Hemost, 1992, 18(4): 353-372.
2. Goad KE, Gralnick HR. Coagulation disorders in cancer. Hematol Oncol Clin North Am, 1996, 10(2): 457-484.
3. Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trosseau's syndrome revisited. Blood, 1983, 62(1): 14-31.
4. Kwaan HC, Keer HN. Fibrinolysis and cancer. SeminThromb Hemost, 1990, 16(3): 230-235.
5. Gabazza EC, Taguchi O, Yamakami T, et al. Evaluating prethrombotic state in lung cancer using molecular markers. Chest, 1993, 103(1): 196-200.
6. Wada H, Kobayashi T, Abe Y, et al. Elevated levels of soluble fibrin or d-dimer indicate high risk of thrombosis. J Thromb Haemost, 2006, 4(6): 1253-1258.
7. Bockenstedt P. D-dimer in venous thromboembolism. N Engl J Med, 2003, 349(13): 1203-1204.
8. Antoniou D, Pavlakou G, Stathopoulos GP, et al. Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer. Lung Cancer, 2006, 53(2): 205-210.
9. Buccheri G, Torchio P, Ferrigno D. Plasma levels of D-dimer in lung carcinoma: clinical and prognostic significance. Cancer, 2003, 97(12): 3044-3052.
10. Pavey SJ, Hawson GA, Marsh NA. Impact of the fbrinolytic enzyme system on prognosis and survival associated with non-small cell lung carcinoma. Blood Coagulation and Fibrinolysis, 2001, 12(1): 51-58.
11. Altiay G, Ciftci A, Demir M, et al. High plasma D-dimer level is associated with decreased survival in patients with lung cancer. Clin Oncol (R Coll Radiol), 2007, 19(7): 494-498.
12. Tricerri A, Vangeli M, Errani AR, et al. Plasma thrombin-antithrombin complexes, latent coagulation disorders and metastatic spread in lung cancer: a longitudinal study. Oncology, 1996, 53(6): 455-460.
13. Im JH, Fu W, Wang H, et al. Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res, 2004, 64(23): 8613-8619.
14. Sawada M, Miyake S, Ohdama S, et al. Expression of tissue factor in nonsmall- cell lung cancers and its relationship to metastasis. Br J Cancer, 1999, 79(3/4): 472-477.
15. Goldin-Lang P, Tran QV, Fichtner I, et al. Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumor metastasis. Oncol Rep, 2008, 20(1): 123-128.
16. Keller T, Salge U, Konig H, et al. Tissue factor is the only activator of coagulation in cultured human lung cancer cells. Lung Cancer, 2001, 31(2/3): 171-179.
17. Buccheri G, Ferrigno D, Ginardi C, et al. Haemostatic abnormalities in lung cancer: prognostic implications. Eur J Cancer, 1997, 33(1): 50-55.
18. Marinho FC, Takagaki TY. Hypercoagulability and lung cancer. J Bras Pneumol, 2008, 34(5): 312-322.
19. Gieseler F, Lr I, Kunze T, et al. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy. Thromb Haemost, 2007, 97(6): 1023-1030.
20. Ferrigno D, Buccheri G, Ricca I. Prognostic significance of blood coagulation tests in lung cancer. Eur Respir J, 2001, 17(4): 667-673.
21. Borensztajn K, Bijlsma MF, Reitsma PH, et al. Coagulation factor Xa inhibits cancer cell migration via protease-activated receptor-1 activation. Thromb Res, 2009, 124(2): 219-225.
22. Hembrough TA, Swartz GM, Papathanassiu A, et al. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. Cancer Res, 2003, 63(11): 2997-3000.
23. Stathopoulosb P. Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer. Lung Cancer, 2006, 53(2): 205-210.
24. Taguchi O, Gabazza EC, Yasui H, et al. Prognostic significance of plasma D-dimer levels in patients with lung cancer. Thorax, 1997, 52(6): 563-565.
25. Xu C, Fu X. The changes of blood coagulation in surgical patients with lung cancer. Zhongguo Fei Ai Za Zhi, 2010, 13(2): 136-139.
26. Koo HK, Jin SM, Lee CH, et al. Factors associated with recurrence in patients with curatively resected stage I-II lung cancer. 2010 Dec 16. [Epub ahead of print]